|  |  | Total | Survival | Death | p value |
---|---|---|---|---|---|---|
Characteristic | Sex (%) | Male/Female | 195 (73)/70 (26.4) | 185 (74)/65 (26) | 10 (66.7)/5 (33.3) | 0.551 |
Age (mean ± SD) |  | 71.2 ± 12.7 | 71.1 ± 12.7 | 73.3 ± 12.2 | 0.509 | |
Drug | Aspirin (%) | Â | 118 (44.9) | 111 (44.8) | 7 (46.7) | 0.131 |
Aspirin + Clopidogrel (%) | Â | 45 (17.1) | 44 (17.7) | 1 (6.7) | 0.479 | |
Anticoagulant drugs (%) | Â | 72 (27.4) | 65 (26.2) | 7 (46.7) | 0.131 | |
Other antiplatelet drugs (%) | Â | 10 (3.8) | 10 (4.0) | 0 (0.0) | > 0.999 | |
NSAIDs (%) | Â | 53 (20.1) | 50 (20.1) | 3 (20.0) | > 0.999 | |
Preventive drugs (%) | H2RA/PPI/MPAs | 31 (11.7)/51 (19.2)/21 (7.9) | 30 (12.0)/46 (18.4)/19 (7.6) | 1 (6.7)/5 (33.3)/2 (13.3) | 0.047 |